A(2B) adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models

BACKGROUND: Adenosine is a metabolite that suppresses antitumor immune response of T and NK cells via extracellular binding to the two subtypes of adenosine-2 receptors, A(2)ARs. While blockade of the A(2A)ARs subtype effectively rescues lymphocyte activity, with four A(2A)AR antagonists currently i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tay, Apple Hui Min, Prieto-Díaz, Rubén, Neo, Shiyong, Tong, Le, Chen, Xinsong, Carannante, Valentina, Önfelt, Björn, Hartman, Johan, Haglund, Felix, Majellaro, Maria, Azuaje, Jhonny, Garcia-Mera, Xerardo, Brea, Jose M, Loza, Maria I, Jespers, Willem, Gutierrez-de-Teran, Hugo, Sotelo, Eddy, Lundqvist, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115112/
https://www.ncbi.nlm.nih.gov/pubmed/35580926
http://dx.doi.org/10.1136/jitc-2022-004592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115112/
https://www.ncbi.nlm.nih.gov/pubmed/35580926
http://dx.doi.org/10.1136/jitc-2022-004592

Ejemplares similares